Publications by authors named "William E Janssen"

Claim this Profile
L
Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial.
Rosa Nguyen, Natasha Sahr, April Sykes, Mary Beth McCarville, Sara M Federico, William E Janssen

J Immunother Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia.
Rosa Nguyen, Huiyun Wu, Stanley Pounds, Hiroto Inaba, Raul C Ribeiro, William E Janssen

J Immunother Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma.
Sara M Federico, M Beth McCarville, Barry L Shulkin, Paul M Sondel, Jacquelyn A Hank, William E Janssen

Clin Cancer Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation.
Joseph Pidala, Jongphil Kim, Heather Jim, Mohamed A Kharfan-Dabaja, Taiga Nishihori, William E Janssen

Haematologica· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: clinical and economic outcomes.
Janelle B Perkins, Jamie F Shapiro, Ryan N Bookout, Gary C Yee, Claudio Anasetti, William E Janssen

Am J Hematol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell therapy medical tourism: time for action.
Kurt C Gunter, Arthur L Caplan, Chris Mason, Rachel Salzman, William E Janssen

Cytotherapy· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.
Alberto A Chiappori, Hatem Soliman, William E Janssen, Scott J Antonia, Dmitry I Gabrilovich

Expert Opin Biol Ther· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale Ficoll gradient separations using a commercially available, effectively closed, system.
William E Janssen, Albert Ribickas, Laura V Meyer, Renee C Smilee

Cytotherapy· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation.
Paul Fallon, Tracy Gentry, Andrew E Balber, David Boulware, William E Janssen

Br J Haematol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis